Public Event Detail
Aditxt names Jeffrey Busch as interim CEO By Investing.com
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Event summary
Aditxt Inc. (NASDAQ:ADTX) has appointed Jeffrey M. Busch as interim chief executive officer, effective Saturday, following the resignation of co-founder Amro Albanna. Busch, who previously led Global Medical REIT Inc. and currently heads Aditxt's subsidiary Ignite Proteomics LLC, takes the helm as the company faces significant financial challenges, including a rapidly burning cash reserve and substantial debt. Aditxt has also recently announced a reverse stock split, a private placement of senior unsecured notes, and an increase in its at-the-market offering size to address its financial situation and regain Nasdaq compliance.